miRNAs as biomarkers of adverse drug reactions to platinum-based agents in patients with non-small-cell lung cancer.
Pedro Eduardo do Nascimento Silva VasconcelosMarília Berlofa VisacriEder de Carvalho PincinatoNadine de Godoy TorsoCecília S SeguinLair ZambonAristóteles de S BarbeiroMauricio Wesley Perroud JuniorPatricia MorielPublished in: Biomarkers in medicine (2021)